Peripheral Blood Stem Cell TransplantationHematopoietic Stem Cell TransplantationTransplantation, HomologousTransplantation, AutologousStem Cell TransplantationGraft vs Host DiseaseTransplantation ConditioningBone Marrow TransplantationHematologic NeoplasmsHematopoietic Stem Cell MobilizationGranulocyte Colony-Stimulating FactorStem CellsTransplantation ChimeraLeukapheresisMelphalanTissue DonorsBusulfanGraft SurvivalMyeloablative AgonistsTreatment OutcomeCombined Modality TherapyAntigens, CD34RecurrenceMultiple MyelomaHematopoietic Stem CellsRemission InductionCyclophosphamideCord Blood Stem Cell TransplantationBlood Component RemovalGraft vs Leukemia EffectAntineoplastic Combined Chemotherapy ProtocolsVidarabineHistocompatibility TestingHistocompatibilityImmunosuppressive AgentsWhole-Body IrradiationRetrospective StudiesDisease-Free SurvivalLeukemiaSalvage TherapyLymphoma, Non-HodgkinLeukemia, Myeloid, AcuteSurvival AnalysisSurvival RateGraft vs Tumor EffectEtoposideCytomegalovirus InfectionsLeukemia, Myelogenous, Chronic, BCR-ABL PositiveAntineoplastic Agents, AlkylatingMyelodysplastic SyndromesLiver TransplantationLymphocyte DepletionInfectionTime FactorsTransplantation, IsogeneicLymphocyte TransfusionThiotepaCytarabinePrecursor Cell Lymphoblastic Leukemia-LymphomaAnemia, AplasticHodgkin DiseaseSiblingsPOEMS SyndromeHematopoiesisNeoplasm, ResidualVincristineFollow-Up StudiesHLA AntigensMesenchymal Stem Cell TransplantationHematologic DiseasesAntilymphocyte SerumBlood DonorsAmyloidosisCarmustineT-LymphocytesImmunosuppressionFatal OutcomeKidney TransplantationAcute DiseaseLymphomaCell TransplantationBlood CellsOpportunistic InfectionsIfosfamideCyclosporinePrognosisTransplantation ImmunologyEmbryonic Stem CellsChimerismMinor Histocompatibility AntigensHepatic Veno-Occlusive DiseasePlatelet CountAntineoplastic AgentsBone MarrowProspective StudiesNeoplasmsVirus ActivationImmunophenotypingFeasibility StudiesAdult Stem Cells